Therefore, the TGF-β1-activated Smad3 signaling pathway is critical for the development of hepatic fibrosis, and TGF-β signaling pathways are potential therapeutic targets for liver fibrosis [27–29]. Here, SMAD3 is linked to Hepatic fibrosis.